Approval · Notice of Compliance 13462 · 2012
XIAFLEX: Notice of Compliance 13462
Issued July 5, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13462
- Date
- July 5, 2012
- Company
- Auxilium Pharmaceuticals Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Collagenase Clostridium Histolyticum
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XIAFLEX | 02388316 | Cancelled Post Market |
Medicinal ingredients
- COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG per VIAL